https://scholars.lib.ntu.edu.tw/handle/123456789/145338
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 臺大醫院;臺大醫學院-臨床醫學研究所; | - |
dc.contributor.author | Yau, Thomas Cheung | en |
dc.contributor.author | Sukeepaisarnjaroen, Wattana | en |
dc.contributor.author | Chao, Yee | en |
dc.contributor.author | Yen, Chia-Jui | en |
dc.contributor.author | Lausoontornsiri, Wirote | en |
dc.contributor.author | Chen, Pei-Jer | en |
dc.contributor.author | Sanpajit, Theeranun | en |
dc.contributor.author | Lencioni, Riccardo | en |
dc.contributor.author | Camp, Aaron C. | en |
dc.contributor.author | Cox, Donna S. | en |
dc.contributor.author | Kallender, Howard | en |
dc.contributor.author | Ottesen, Lone Harild | en |
dc.contributor.author | Poon, Ronnie Tung-Ping | en |
dc.creator | Yau, Thomas Cheung;Sukeepaisarnjaroen, Wattana;Chao, Yee;Yen, Chia-Jui;Lausoontornsiri, Wirote;Chen, Pei-Jer;Sanpajit, Theeranun;Lencioni, Riccardo;Camp, Aaron C.;Cox, Donna S.;Kallender, Howard;Ottesen, Lone Harild;Poon, Ronnie Tung-Ping | en |
dc.creator | 陳培哲 | zh-tw |
dc.date | 2012 | - |
dc.date.accessioned | 2017-06-22T06:15:41Z | - |
dc.date.accessioned | 2018-07-06T07:36:42Z | - |
dc.date.available | 2017-06-22T06:15:41Z | - |
dc.date.available | 2018-07-06T07:36:42Z | - |
dc.date.issued | 2012 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/279558 | - |
dc.language | en-us | - |
dc.relation | J. Clin. Oncol., 30(15), | - |
dc.relation.ispartof | J. Clin. Oncol. | - |
dc.title | A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC). | - |
dc.relation.pages | - | - |
dc.relation.journalvolume | 30 | - |
dc.relation.journalissue | 15 | - |
item.grantfulltext | none | - |
item.fulltext | no fulltext | - |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。